1Schiffman M, Kjaer SK. Chapter 2: Natural History of Ano- genital Human Papillomavirus Infection and Neoplasia[J]. J Natl Cancer Inst Monogr, 2003,31 : 9-- 14.
2Shi J F, Qiao YI, Smith J S, et al.Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongo- lia[J].Vaecine,2008,26(Suppl 12) :53-59.
3Kin CJ, Jeong JK, Park M, et al. HPV oligonucleotide microar- ray--based detection of HPV genotypes in cervical neoplasti- elestions[J]. Gynecol Oncol, 2003,89 (2) : 210-- 217.
4Nagpal JK,Sahai S, Das BR. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus 2 asso- ciated cervical cancer in Indian women[J]. Eur J Clin lnvest, 2002,32 (12) : 943- 948.
5Das BC,Sharma JK,Gopalkrishna V,et al.A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction[J].J Med Virol, 1992,36 : 239- 245.
9Ferber MJ,Montoya DP,Yu C,et al.Integrations of the hepatitis B (HBV) and human pepillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancer[J].Oncogene,2003,22 (24):3813-3820.
10Franceschi S.The IARC commitment to cancer prevention:the example of papillomavirus and cervical cancer[J].Recent Results Cancer Res,2005,166 (3):277-297.
